| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/26/2006 | CN1253439C Process for preparing milrinone |
| 04/26/2006 | CN1253438C Process for large-scale preparation of 2-hydroxyethyl pyridine |
| 04/26/2006 | CN1253437C Medicinal compound for curing disease of gastrointestinal tract, preparation method and relevant medication |
| 04/26/2006 | CN1253151C Use of MGLUR 5 antagonists for treatment of pruritic conditions |
| 04/25/2006 | US7034160 Anticoagulants, methyl (2R,3R)-2-(3-(amino(imino)methyl)benzyl)-3-((4-(1-oxido-4-pyridinyl) benzoyl)amino)butanoate; therapeutic treatment of cardiovascular disorders |
| 04/25/2006 | US7034159 Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034046 NR1H4 nuclear receptor binding compounds |
| 04/25/2006 | US7034045 Monofluoroalkyl derivatives |
| 04/25/2006 | US7034044 NMDA (N-methyl-D- aspartate)-receptor subtype blockers and are used in the treatment or prevention of CNS disorders i.e. Alzheimer's, Parkinson's, etc. |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7033578 Antimycotic nail varnish composition |
| 04/25/2006 | US7033401 3-Aminophenol derivatives substituted in the 2-position, and dyes containing these compounds |
| 04/25/2006 | CA2237313C Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/25/2006 | CA2167291C Substituted 2-phenylpyridines with herbicidal action |
| 04/20/2006 | WO2006041197A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ |
| 04/20/2006 | WO2006041121A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | WO2006041120A1 Pharmaceutical composition |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006041046A1 Pyridine derivative |
| 04/20/2006 | WO2006041037A1 Novel pyridine derivative |
| 04/20/2006 | WO2006040645A1 N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma |
| 04/20/2006 | WO2006040528A1 Phenoxy benzamide compounds with utility in the treatment of type 2 diabetes and obesity |
| 04/20/2006 | WO2006040527A1 Process for making phenoxy benzamide compounds |
| 04/20/2006 | WO2006040179A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040131A1 Iron or cobalt-catalyzed carbon-carbon coupling reaction of aryls, alkenes and alkines with copper reagents |
| 04/20/2006 | WO2006025979A9 Modulators of nuclear receptors |
| 04/20/2006 | WO2006015194A3 Preparation of pyridonecarboxylic acid antibacterials |
| 04/20/2006 | WO2005113513A3 Aryl sulfonamides |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084813 Method for producing alkenone ethers |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084648 Ethynyl derivatives as factor xa inhibitors |
| 04/20/2006 | DE19830167B4 Neue Azatyrosin-Analoga New azatyrosine analogues |
| 04/20/2006 | DE102004050196A1 Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted 2-pyridone derivatives, processes for their preparation and their use as a medicament |
| 04/20/2006 | CA2584261A1 Pharmaceutical composition |
| 04/20/2006 | CA2584169A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | CA2583918A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2582588A1 Acyclic hydrazides as cannabinoid receptor modulators |
| 04/20/2006 | CA2581706A1 Process for producing heteroaromatic carboxylic acids |
| 04/20/2006 | CA2581619A1 Process for making phenoxy benzamide compounds |
| 04/19/2006 | EP1647545A1 Antiviral protease inhibitors |
| 04/19/2006 | EP1646661A2 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
| 04/19/2006 | EP1646608A1 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1412331B1 Process for the production of 4-amino-2,5-bisheterocyclylquinazolines |
| 04/19/2006 | EP1385577B1 Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
| 04/19/2006 | EP1383736A4 Peptide deformylase inhibitors |
| 04/19/2006 | EP1240133B1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | EP1120419B1 Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | EP0859772B1 Herbicidal substituted pyridine compounds |
| 04/19/2006 | CN1761653A Processes for the preparation of N-heteroaryl-N-aryl-amines by reacting an N-aryl carbamic acid ester with a halo-heteroaryl and analogous processes |
| 04/19/2006 | CN1761646A Cannabinoid receptor ligands |
| 04/19/2006 | CN1761464A Substituted p-diaminobenzene derivatives |
| 04/19/2006 | CN1760192A Cationic diazo compounds, compositions comprising them, methods for dyeing and kit |
| 04/19/2006 | CN1252069C 2-aryl-naphthyridin-4-ones as antitumor agent |
| 04/19/2006 | CN1252055C Biphenyl carboxamides compounds |
| 04/19/2006 | CN1252048C Process for the preparation of an enantiomerically enriched thio compound |
| 04/18/2006 | US7030268 Reacting acid chloride with phenylalanine in solvent comprising potassium hydroxide; for production drugs |
| 04/18/2006 | US7030256 Metal-ligand complexes has a dianionic ligand chelating to the metal; non-metallocene group 4 complexes as polymerization catalyst for preparing isotactic polypropylene, or copolymers of ethylene/olefin; high molecular weight polypropylene with a high melting point |
| 04/18/2006 | US7030229 Anthraquinone-azo dyes |
| 04/18/2006 | US7030161 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 04/18/2006 | US7030146 Methods for treating diabetic neuropathy |
| 04/18/2006 | US7030145 or anxiety; {3-[4-(2-Methoxybenzyloxy)-benzenesulfonyl]-6-methylpyridin-2-yl}-(4-methoxy-2-methylphenyl)-amine for example |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030120 Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same |
| 04/18/2006 | US7030116 Compounds and compositions as cathepsin inhibitors |
| 04/18/2006 | US7030111 drugs such as 4-chloro-benzoic acid p-tolyl ester, used to control or suppress the onset of mitosis until DNA replication and repair are complete; prophylaxis of proliferative disorders |
| 04/18/2006 | US7029654 anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 04/18/2006 | US7029502 Thermostable dyes; lightfastness |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/18/2006 | CA2129933C Viscosity probe |
| 04/13/2006 | WO2006038741A1 Method for producing thioether compound |
| 04/13/2006 | WO2006038606A1 Biaryl derivative |
| 04/13/2006 | WO2006038587A1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 04/13/2006 | WO2006037982A2 Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases |
| 04/13/2006 | WO2006037761A1 New histone deacetylases inhibitors |
| 04/13/2006 | WO2006037496A1 Polyhalogenated propene benzoquinone dioxime derivatives and its use as pesticides |
| 04/13/2006 | WO2006028958A3 Pyridyl inhibitors of hedgehog signalling |
| 04/13/2006 | WO2006010546A3 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079719 Aminated compounds bearing at least an allyl and a difluoromethyl and method used for synthesis thereof |
| 04/13/2006 | US20060079691 Ionic liquids having [n(cf3)2]-anions |
| 04/13/2006 | US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079561 Insecticidal anthranilamides |
| 04/13/2006 | US20060079551 Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors |
| 04/13/2006 | US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | US20060079484 Antithrombotic effect |
| 04/13/2006 | US20060078767 Odorant, liquid fuel for fuel cell and fuel cell |
| 04/13/2006 | DE102004023635A1 Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate Heteroaryl-cyclohexyl-1,4-diamine derivatives |
| 04/13/2006 | CA2582658A1 Method for producing thioether compound |